Magnesium News and Research

RSS

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Amgen today announced the publication of results from a pivotal Phase 3 study of 1,776 advanced cancer patients with different types of solid tumors or multiple myeloma, which compared XGEVA to Zometa in preventing skeletal-related events.

23 Feb 2011

Medical expert speaks about effects of sugar on human body

With the many forms of sugar available, from table sugar, to high-fructose corn syrup to agave and honey, understanding the differences between sugars and their effects on the body is not all sweet.

18 Feb 2011

Study finds water softener does not provide benefit to children with eczema

The first study of its kind in the world — involving 336 children aged between six months and 16 years old — has shown that installing a water softener for three months brings no additional relief for eczema sufferers.

16 Feb 2011

USDA nutrient dosage recommendations not sufficient, says USANA

USANA Health Sciences, Inc. commends the USDA for recognizing that nutritional gaps are common in the average American diet and that dietary supplementation can play a vital role in filling those gaps. However, USANA scientists and advising physicians caution that many important nutrients were not included in the recently published Dietary Guidelines for Americans, 2010 and that the USDA dosage recommendations are not sufficient to improve and maintain overall health.

15 Feb 2011

Surgical procedure to repair spina bifida while still in the uterus may help the baby walk after birth

More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, represent major findings in reducing high-risk pregnancies and complications.

11 Feb 2011

Mg significantly reduces neonatal brain injury linked with maternal inflammation, infection

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that showed that in rats, the use of magnesium sulfate significantly reduced the neonatal brain injury associated with maternal inflammation or maternal infection.

10 Feb 2011

Study shows risky knowledge gaps, deficits in dietary supplements among pregnant women

Research conducted by the Chair of Nutritional Medicine at the Technische Universitaet Muenchen indicates there are knowledge gaps: According to this study, pregnant women often start taking sensible dietary supplements too late or not at all. At the same time, other micronutrients are unwittingly overdosed whose effects during pregnancy have not yet been studied.

19 Jan 2011

Organic milk best: Study

The latest research published by Newcastle University, UK has shown that organic milk contains less unhealthy fat, as well as a range of important healthy nutrients. It contains fewer chemicals and poses less risk for children to develop allergies and eczema. Organic milk is also rich in omega 3 fatty acids that re good for the heart. However it costs more. At least 60 per cent of the diet of organic cows has to be organically grown grass and its traditional derivatives — silage and hay.

18 Jan 2011

New research identifies nutrition inadequacy among Americans

At a time when the country is facing an obesity epidemic, the problem of nutrition inadequacy is often overlooked. Yet, many Americans are overweight and undernourished, concludes a new study called "What America's Missing."

12 Jan 2011

MigreLief releases safe, proven effective supplement for children with migraines

MigreLief, the first name in migraine prevention, releases a safe and proven effective supplement for children of all ages: Children's MigreLief.

24 Dec 2010

Study examines effect of nitrogen fertilizer on low iron soil

An expansion of soybean production into areas where soybean has seldom, if ever, been grown can be problematic for some farmers. Soils having high pH values and large amounts of calcium and/or magnesium carbonate are notoriously iron deficient. Iron deficient soils in the North Central United States are estimated to reduce soy bean production by 12.5 million bushels every year. .

7 Dec 2010

Experts reach consensus on beneficial effects of Soy

According to the December 2010 Journal of Nutrition Supplement titled, "Soy Summit: Exploration of the Nutrition and Health Effects of Whole Soy," consensus has been reached among leading soy science experts surrounding three main areas of debate: soy and women's health, soy and heart health, and soy and overall nutrient adequacy. Leading soy experts agree that including soyfoods in a balanced diet will have beneficial effects and improve nutrient intake among the U.S. population.

3 Dec 2010

Scientologists target Aborigines with “drug bombs”

The Northern Territory (NT) Health Department of Australia last Saturday warned the Church of Scientology that its drug detoxification therapy, being promoted to Aborigines in Australia by the church was dangerous for people with kidney problems.

21 Nov 2010

Metallic particles in smoke from fireworks affect human health

The metallic particles in the smoke emitted by fireworks pose a health risk, particularly to people who suffer from asthma. This is the conclusion of a study led by researchers from the Institute of Environmental Assessment and Water Research (IDAEA-CSIC), published this week in the Journal of Hazardous Materials.

17 Nov 2010

VIMOVO granted marketing and pricing approval in the UK

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has been notified by AstraZeneca that marketing and pricing approval for VIMOVO™ (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets, has been granted in the United Kingdom (UK).

12 Nov 2010

New study highlights benefits of 100% juice

With so few Americans consuming the recommended amounts of fruit each day, finding quick and simple ways to add additional fruit servings - and the important nutrients they provide - is more critical than ever. Although USDA recognizes that 4-oz of 100 percent juice supplies one serving (1/2 cup) of fruit, there is still confusion regarding the healthfulness of juice.

9 Nov 2010

TRPM7 protein plays a key role in maintenance of magnesium homeostasis

An international team led by researchers at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School has published new findings that demonstrate how a specific protein controls the body's ability to balance magnesium levels. Magnesium is an essential element for good health and is critical to more than 300 biochemical reactions that occur in the body.

8 Nov 2010

POZEN’s therapeutic development programs qualified to receive federal grant under PPACA

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that three of the Company's therapeutic development programs, VIMOVO (naproxen / esomeprazole magnesium) (formerly PN400), PA32540 and PA65020, qualified to receive federal grant funding under The Patient Protection and Affordable Care Act.

3 Nov 2010

Dr Sartori’s contentious alternative therapy: inquest date set

The Medical Practitioner's Board of Western Australia is looking into the case of a doctor and her role in an alternative cancer therapy program. Five cancer patients have died after apparently being given industrial solvents and dangerous minerals as a part of an alternative therapy program by Alexandra Boyd, a well-known Mosman Park breast cancer specialist. She along with two registered nurses administered the concoctions to the people in question.

1 Nov 2010

POZEN reports net loss of $8.6M for third quarter 2010 vs. net income of $6.7M for third quarter 2009

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the third quarter ended September 30, 2010.

28 Oct 2010